Faculty Disclosures

Article Outline

 

The authors who contributed to this publication have disclosed the following industry relationships:

Philip Barter, MD, PhD, serves as a consultant to Astra Zeneca Pharmaceuticals, CSL Pharmaceuticals, Merck & Co., Inc. Pfizer, Inc. Roche Pharmaceuticals, and Sanofi-Aventis; has received honoraria from Abbott Laboratories, Astra Zeneca Pharmaceuticals, Merck & Co., Inc. Pfizer, Inc. Roche Pharmaceuticals, and Sanofi-Aventis; and has participated in sponsored clinical trials from Astra Zeneca Pharmaceuticals, Merck & Co., Inc. Pfizer, Inc. Roche Pharmaceuticals.

Michael H. Davidson, MD, is a member of the Speakers' Bureau for Abbott Laboratories, Astra Zeneca Pharmaceuticals, Merck & Co., Inc., Merck/Schering-Plough, Diichi-Sanyo, and Takeda Pharmaceuticals; serves as a consultant to Abbott Laboratories, Astra Zeneca Pharmaceuticals, Merck & Co., Inc., Merck/Schering-Plough, Roche Pharmaceuticals, Diichi-Sanyo, and Takeda Pharmaceuticals; and has received research/grant support from Abbott Laboratories, Astra Zeneca Pharmaceuticals, Merck & Co., Inc., Merck/Schering-Plough, Roche Pharmaceuticals, Diichi-Sanyo, and Takeda Pharmaceuticals.

Prakash Deedwania, MD, is a Member of the Speakers' Bureau for Pfizer,Inc., Astra Zeneca Pharmaceuticals, Novartis Pharmaceuticals Corp,Gilead and Glasco Smith Kline Pharmaceuticals and serves as a Consultant to Pfizer, Inc., Novartis Pharmaceuticals, Gilead, and Glasco Smith Kline Pharmaceuticals.

G. Kees Hovingh, MD, PhD has no financial arrangement or affiliation with a corporate organization or manufacturer of a product discussed in this supplement.

John J.P. Kastelein, MD, PhD serves as a consultant to Eli Lilly, Merck Sharp & Dohme, Roche Pharmaceuticals, Novartis Pharmaceuticals, Cerenis Therapeutics, Solvay Pharmaceuticals and receives research grants from Roche Pharmaceuticals and Merck Sharp & Dohme

Stephen Nicholls, MBBS, PhD has received honoraria from AstraZeneca Pharmaceuticals, Roche Pharmaceuticals, Merck Schering-Plough, Pfizer Inc., and Takeda, serves as a consultant to AstraZeneca, Roche Pharmaceuticals, Merck Schering-Plough, Anthera, LipoScience, Pfizer Inc, Takeda Pharmaceuticals and Novo-Nordisk and has received research support from AstraZeneca Pharmaceuticals, Novartis Pharmaceuticals and Resverlogix.

Robert S. Rosenson, MD, is a member of the Speaker's Bureau for Abbott Laboratories and Astra Zeneca, serves as a consultant to Anthera Pharmaceuticals, Daichi Sankyo and LipoScience, Inc., has received research/grant support from Abbott Laboratories, Anthera Pharmaceuticals, Astra Zeneca, Genzyme and Sanofi Aventis, Inc.

Gregory G. Schwartz, MD, PhD, has received research support from Roche Pharmaceuticals

Vibhuti Singh, MD, is a member of Speaker's Bureau for Schering-Plough, The Medicine's Company, and Eli Lilly; has received research support from Pfizer Inc., Astra-Zeneca, Sankyo Pharmaceuticals, Schering-Plough, Sanofi-Synthelabo Inc., Gilead, Novartis, and Otsuka

Aart C. Strang, MD, has no financial arrangement or affiliation with a corporate organization or manufacturer of a product discussed in this supplement.

Erik S.G. Stroes, MD, PhD, has received lecture fees from Roche Pharmaceuticals, Novartis Pharmaceuticals and Merck & Co.

Alan R. Tall, MD, serves as a consultant to Merck Research Laboratories, Roche Pharmaceuticals,Bristol Myers Squibb, Commonwealth Serum Laboratories and Arisaph, and has received research support from Merck & Co., Inc. and Roche Pharmaceuticals

Menno Vergeer, MD, has no financial arrangement or affiliation with a corporate organization or manufacturer of a product discussed in this supplement.